[1] K. Ohtsubo, J.D. Marth, Glycosylation in cellular mechanisms of health and disease, Cell 126 (5) (2006) 855–867.
[2] K.W. Moremen, M. Tiemeyer, A.V. Nairn, Vertebrate protein glycosylation: diversity, synthesis and function, Nat. Rev. Mol. Cell Biol. 13 (7) (2012) 448–462.
[3] D.J. Becker, J.B. Lowe, Fucose: biosynthesis and biological function in mammals, Glycobiology 13 (7) (2003) 41r–53r.
[4] N.D. Avent, Human erythrocyte antigen expression: its molecular bases, Br. J. Biomed. Sci. 54 (1) (1997) 16–37.
[5] J.B. Lowe, The blood group-specific human glycosyltransferases, Baillieres Clin Haematol 6 (2) (1993) 465–492.
[6] L. Fagerberg, B.M. Hallstrom, P. Oksvold, C. Kampf, D. Djureinovic, J. Odeberg,M. Habuka, S. Tahmasebpoor, A. Danielsson, K. Edlund, A. Asplund, E. Sjostedt,E. Lundberg, C.A. Szigyarto, M. Skogs, J.O. Takanen, H. Berling, H. Tegel,J. Mulder, P. Nilsson, J.M. Schwenk, C. Lindskog, F. Danielsson, A. Mardinoglu,A. Sivertsson, K. von Feilitzen, M. Forsberg, M. Zwahlen, I. Olsson, S. Navani,M. Huss, J. Nielsen, F. Ponten, M. Uhlen, Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics, Mol. Cell. Proteomics 13 (2) (2014) 397–406.
[7] J.M. Pickard, C.F. Maurice, M.A. Kinnebrew, M.C. Abt, D. Schenten, T.V. Golovkina, S.R. Bogatyrev, R.F. Ismagilov, E.G. Pamer, P.J. Turnbaugh, A.V. Chervonsky, Rapid fucosylation of intestinal epithelium sustains host- commensal symbiosis in sickness, Nature 514 (7524) (2014) 638–+.
[8] P.C. Kashyap, A. Marcobal, L.K. Ursell, S.A. Smits, E.D. Sonnenburg, E.K. Costello,S.K. Higginbottom, S.E. Domino, S.P. Holmes, D.A. Relman, R. Knight, J.I. Gordon,J.L. Sonnenburg, Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota, Proc. Natl. Acad. Sci. U. S. A. 110 (42) (2013) 17059–17064.
[9] T.A. Pham, S. Clare, D. Goulding, J.M. Arasteh, M.D. Stares, H.P. Browne, J.A. Keane, A.J. Page, N. Kumasaka, L. Kane, L. Mottram, K. Harcourt, C. Hale, M.J. Arends, D.J. Gaffney, G. Dougan, T.D. Lawley, Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen, Cell Host Microbe 16 (4) (2014) 504–516.
[10] Y. Goto, T. Obata, J. Kunisawa, S. Sato, Ivanov II, A. Lamichhane, N. Takeyama,M. Kamioka, M. Sakamoto, T. Matsuki, H. Setoyama, A. Imaoka, S. Uematsu,S. Akira, S.E. Domino, P. Kulig, B. Becher, J.C. Renauld, C. Sasakawa, Y. Umesaki,Y. Benno, H. Kiyono, Innate lymphoid cells regulate intestinal epithelial cell glycosylation, Science 345 (6202) (2014) 1254009.
[11] A. Suwandi, A. Galeev, R. Riedel, S. Sharma, K. Seeger, T. Sterzenbach, L. García Pastor, E. Boyle, O. Gal-Mor, M. Hensel, J. Casadesús, J. Baines, G. Grassl, Std fimbriae-fucose interaction increases Salmonella-induced intestinal inflammation and prolongs colonization, PLoS Pathog. 15 (7) (2019).
[12] D. Chessa, M. Winter, M. Jakomin, A. Ba¨umler, Salmonella enterica serotype Typhimurium Std fimbriae bind terminal alpha(1,2)fucose residues in the cecal mucosa, Mol. Microbiol. 71 (4) (2009).
[13] E.A. Hurd, S.E. Domino, Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis, Infect. Immun. 72 (7) (2004)4279–4281.
[14] A. Magalhaes, Y. Rossez, C. Robbe-Masselot, E. Maes, J. Gomes, A. Shevtsova,J. Bugaytsova, T. Boren, C.A. Reis, Muc5ac gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding, Sci. Rep. 6 (2016) 25575.
[15] E. Kindberg, B. Akerlind, C. Johnsen, J.D. Knudsen, O. Heltberg, G. Larson,B. Bottiger, L. Svensson, Host genetic resistance to symptomatic norovirus (GGII.4) infections in Denmark, J. Clin. Microbiol. 45 (8) (2007) 2720–2722.
[16] J. Rodriguez-Diaz, I. Garcia-Mantrana, S. Vila-Vicent, R. Gozalbo-Rovira, J. Buesa,V. Monedero, M.C. Collado, Relevance of secretor status genotype and microbiota composition in susceptibility to rotavirus and norovirus infections in humans, Sci. Rep. 7 (2017) 45559.
[17] L. Lindesmith, C. Moe, S. Marionneau, N. Ruvoen, X. Jiang, L. Lindblad, P. Stewart,J. LePendu, R. Baric, Human susceptibility and resistance to Norwalk virus infection, Nat. Med. 9 (5) (2003) 548–553.
[18] F.U. Weiss, C. Schurmann, A. Guenther, F. Ernst, A. Teumer, J. Mayerle, P. Simon,H. Volzke, D. Radke, A. Greinacher, J.P. Kuehn, M. Zenker, U. Volker, G. Homuth,M.M. Lerch, Fucosyltransferase 2 (FUT2) non-secretor status and blood group B are associated with elevated serum lipase activity in asymptomatic subjects, and an increased risk for chronic pancreatitis: a genetic association study, Gut 64 (4) (2015) 646–656.
[19] C. Rupp, K. Friedrich, T. Folseraas, A. Wannhoff, K.A. Bode, K.H. Weiss,P. Schirmacher, P. Sauer, W. Stremmel, D.N. Gotthardt, Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis, Aliment. Pharmacol. Ther. 39 (8) (2014) 873–882.
[20] D.J. Smyth, J.D. Cooper, J.M. Howson, P. Clarke, K. Downes, T. Mistry, H. Stevens,N.M. Walker, J.A. Todd, FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection, Diabetes 60 (11) (2011) 3081–3084.
[21] D.P. McGovern, M.R. Jones, K.D. Taylor, K. Marciante, X. Yan, M. Dubinsky,A. Ippoliti, E. Vasiliauskas, D. Berel, C. Derkowski, D. Dutridge, P. Fleshner, D.Q. Shih, G. Melmed, E. Mengesha, L. King, S. Pressman, T. Haritunians, X. Guo, S.R. Targan, J.I. Rotter, Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn’s disease, Hum. Mol. Genet. 19 (17) (2010) 3468–3476.
[22] A. Franke, D.P. McGovern, J.C. Barrett, K. Wang, G.L. Radford-Smith, T. Ahmad, C.W. Lees, T. Balschun, J. Lee, R. Roberts, C.A. Anderson, J.C. Bis, S. Bumpstead,D. Ellinghaus, E.M. Festen, M. Georges, T. Green, T. Haritunians, L. Jostins,A. Latiano, C.G. Mathew, G.W. Montgomery, N.J. Prescott, S. Raychaudhuri, J.I. Rotter, P. Schumm, Y. Sharma, L.A. Simms, K.D. Taylor, D. Whiteman,C. Wijmenga, R.N. Baldassano, M. Barclay, T.M. Bayless, S. Brand, C. Buning,A. Cohen, J.F. Colombel, M. Cottone, L. Stronati, T. Denson, M. De Vos, R. D’Inca,M. Dubinsky, C. Edwards, T. Florin, D. Franchimont, R. Gearry, J. Glas, A. Van Gossum, S.L. Guthery, J. Halfvarson, H.W. Verspaget, J.P. Hugot, A. Karban,D. Laukens, I. Lawrance, M. Lemann, A. Levine, C. Libioulle, E. Louis, C. Mowat,W. Newman, J. Panes, A. Phillips, D.D. Proctor, M. Regueiro, R. Russell,P. Rutgeerts, J. Sanderson, M. Sans, F. Seibold, A.H. Steinhart, P.C. Stokkers,L. Torkvist, G. Kullak-Ublick, D. Wilson, T. Walters, S.R. Targan, S.R. Brant, J.D. Rioux, M. D’Amato, R.K. Weersma, S. Kugathasan, A.M. Griffiths, J.C. Mansfield, S. Vermeire, R.H. Duerr, M.S. Silverberg, J. Satsangi, S. Schreiber, J.H. Cho, V. Annese, H. Hakonarson, M.J. Daly, M. Parkes, Genome-wide meta- analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci, Nat. Genet. 42 (12) (2010) 1118–1125.
[23] E. Meijerink, S. Neuenschwander, R. Fries, A. Dinter, H. Bertschinger,G. Stranzinger, P. Vo¨geli, A DNA polymorphism influencing alpha(1,2) fucosyltransferase activity of the pig FUT1 enzyme determines susceptibility of small intestinal epithelium to Escherichia coli F18 adhesion, Immunogenetics 52 (1–2) (2000).
[24] Y. Urata, W. Saiki, Y. Tsukamoto, H. Sago, H. Hibi, T. Okajima, H. Takeuchi, Xylosyl extension of O-glucose glycans on the extracellular domain of NOTCH1 and NOTCH2 regulates notch cell surface trafficking, Cells 9 (5) (2020).
[25] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (5259) (1970) 680–685.
[26] S. Alam, Y. Tsukamoto, M. Ogawa, Y. Senoo, K. Ikeda, Y. Tashima, H. Takeuchi,T. Okajima, N-Glycans on EGF domain-specific O-GlcNAc transferase (EOGT) facilitate EOGT maturation and peripheral endoplasmic reticulum localization,J. Biol. Chem. 295 (25) (2020).
[27] M. Lin, I. Munshi, A. Ouellette, The defensin-related murine CRS1C gene: expression in Paneth cells and linkage to Defcr, the cryptdin locus, Genomics 14 (2) (1992).
[28] M. Ismail, E. Stone, M. Panico, S. Lee, Y. Luu, K. Ramirez, S. Ho, M. Fukuda,J. Marth, S. Haslam, A. Dell, High-sensitivity O-glycomic analysis of mice deficient in core 2 {beta}1,6-N-acetylglucosaminyltransferases, Glycobiology 21 (1) (2011).
[29] L. Bry, P. Falk, T. Midtvedt, J. Gordon, A model of host-microbial interactions in an open mammalian ecosystem, Science 273 (5280) (1996).
[30] H. Cash, C. Whitham, C. Behrendt, L. Hooper, Symbiotic bacteria direct expression of an intestinal bactericidal lectin, Science 313 (5790) (2006).
[31] S.H. White, W.C. Wimley, M.E. Selsted, Structure, function, and membrane integration of defensins, Curr. Opin. Struct. Biol. 5 (4) (1995) 521–527.
[32] T. Ayabe, D.P. Satchell, C.L. Wilson, W.C. Parks, M.E. Selsted, A.J. Ouellette, Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria, Nat. Immunol. 1 (2) (2000) 113–118.
[33] Y. Shirafuji, H. Tanabe, D. Satchell, A. Henschen-Edman, C. Wilson, A. Ouellette, Structural determinants of procryptdin recognition and cleavage by matrix metalloproteinase-7, J. Biol. Chem. 278 (10) (2003).
[34] K. Masuda, N. Sakai, K. Nakamura, S. Yoshioka, T. Ayabe, Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria, Journal of innate immunity 3 (3) (2011).
[35] N. Salzman, K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjo¨berg, E. Amir, P. Teggatz,M. Barman, M. Hayward, D. Eastwood, M. Stoel, Y. Zhou, E. Sodergren,G. Weinstock, C. Bevins, C. Williams, N. Bos, Enteric defensins are essential regulators of intestinal microbial ecology, Nat. Immunol. 11 (1) (2010).
[36] M.E. Selsted, A.J. Ouellette, Mammalian defensins in the antimicrobial immune response, Nat. Immunol. 6 (6) (2005) 551–557.
[37] K.M. Huttner, M.E. Selsted, A.J. Ouellette, Structure and diversity of the murine cryptdin gene family, Genomics 19 (3) (1994) 448–453.
[38] M. Shanahan, H. Tanabe, A. Ouellette, Strain-specific polymorphisms in Paneth cell α-defensins of C57bl/6 mice and evidence of vestigial myeloid α-defensin pseudogenes, Infect. Immun. 79 (1) (2011).
[39] A.J. Ouellette, J.C. Lualdi, A novel mouse gene family coding for cationic, cysteine- rich peptides. Regulation in small intestine and cells of myeloid origin, J. Biol. Chem. 265 (17) (1990) 9831–9837.
[40] M. Hornef, K. Pütsep, J. Karlsson, E. Refai, M. Andersson, Increased diversity of intestinal antimicrobial peptides by covalent dimer formation, Nat. Immunol. 5 (8) (2004).